LEADER 02647oam 2200817 450 001 9910715175203321 005 20220509115842.0 024 8 $a41-982 024 8 $a41-983 024 8 $a44-685 035 $a(CKB)5470000002508260 035 $a(OCoLC)1226424437$z(OCoLC)1231540475 035 $a(EXLCZ)995470000002508260 100 $a20201210g20202021 ua 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aUnsustainable drug prices $ehearing before the Committee on Oversight and Reform, House of Representatives 210 1$aWashington :$cU.S. Government Publishing Office,$d2020-2021. 215 $a1 online resource (3 volumes) 300 $a"One Hundred Sixteenth Congress, second session"--Pts. 1 and 2. 300 $a"One Hundred Seventeenth Congress, first session"--Pt. 3. 300 $aAccess ID (govinfo, pt. 1): CHRG-116hhrg41982. 300 $aAccess ID (govinfo, pt. 2): CHRG-116hhrg41983. 300 $a"Serial no. 116-122"--Pt. 1 300 $a"Serial no. 116-123"--Pt. 2 300 $a"Serial no. 117-22"--Pt. 3 300 $a"September 30, 2020"--Pt. 1. 300 $a"October 1, 2020"--Pt. 2. 300 $a"May 18, 2021"--Pt. 3. 517 $aUnsustainable drug prices 606 $aPrescription pricing$zUnited States 606 $aDrugs$xPrices$zUnited States 606 $aPharmaceutical industry$zUnited States$xCosts 606 $aPharmaceutical policy$zUnited States 606 $aDrug development$zUnited States 606 $aDrug development$2fast 606 $aDrugs$xPrices$2fast 606 $aPharmaceutical industry$xCosts$2fast 606 $aPharmaceutical policy$2fast 606 $aPrescription pricing$2fast 607 $aUnited States$2fast 608 $aLegislative hearings.$2fast 608 $aLegislative hearings.$2lcgft 615 0$aPrescription pricing 615 0$aDrugs$xPrices 615 0$aPharmaceutical industry$xCosts. 615 0$aPharmaceutical policy 615 0$aDrug development 615 7$aDrug development. 615 7$aDrugs$xPrices. 615 7$aPharmaceutical industry$xCosts. 615 7$aPharmaceutical policy. 615 7$aPrescription pricing. 676 $a4.OV 2:116-123 801 0$bGPO 801 1$bGPO 801 2$bGPO 801 2$bOCLCO 801 2$bOCLCF 801 2$bDWP 801 2$bGPO 801 2$bOCLCQ 801 2$bOCLCO 801 2$bGPO 906 $aBOOK 912 $a9910715175203321 996 $aUnsustainable drug prices$93522321 997 $aUNINA